Updated Results from DREAMM-3, a Phase 3 Study of Belantamab Mafodotin (belamaf) Versus Pomalidomide Plus Dexamethasone in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)Vania T. M. Hungria,Katja Weisel,Atanas Radinoff,Sosana Delimpasi,Gabor Mikala,Tamas Masszi,Jian Li,Marcelo Capra,Angelo Maiolino,Vasiliki Pappa,Dominik Chraniuk,Iurii Osipov,Xavier Leleu,Michael Low, Fotini Kouri, John Liboon, Chris Brawley,Eric Lewis, Gabriela Tubel,Mary Li,Astrid McKeown,Sumita Roy-Ghanta,Joanna Opalinska,Meletios DimopoulosCLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2024)引用 0|浏览2AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要